Topical Ocular Anti-TNFα Agent Licaminlimab in the Treatment of Acute Anterior Uveitis: A Randomized Phase II Pilot Study

PURPOSE: Licaminlimab is a new anti-TNFα antibody fragment for topical ocular application. This phase II study assessed the tolerability, treatment effect, and pharmacokinetics of licaminlimab in acute anterior uveitis (AAU). METHODS: In this multicenter, randomized, parallel-group, double-masked st...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquali, Theodore A., Toyos, Melissa M., Abrams, David B., Scales, David K., Seaman, John W., Weissgerber, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206391/
https://www.ncbi.nlm.nih.gov/pubmed/35704329
http://dx.doi.org/10.1167/tvst.11.6.14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206391/
https://www.ncbi.nlm.nih.gov/pubmed/35704329
http://dx.doi.org/10.1167/tvst.11.6.14

Ejemplares similares